J Circ Biomark 2023; 12: 1-11 ISSN 1849-4544 | DOI: 10.33393/jcb.2023.2479 ORIGINAL RESEARCH ARTICLE |
Impact of clinico-biochemical variations on the etiopathogenesis of cataract: a case-control study
ABSTRACT
Purpose: Cataract is a major cause of blindness worldwide with a greater prevalence in developing countries like India. Owing to speculations about the relationship of various biochemical markers and cataract formation this case-control study was designed with the aim to know the impact of serum blood sugar, serum electrolytes and serum calcium on the etiopathogenesis of cataract in Kashmiri population.
Methods: A total of 300 cases diagnosed with cataract and 360 healthy controls were taken for the study. Serum of all the cases and controls was analyzed for blood sugar and calcium using spectrometric techniques. Sodium and potassium were analyzed using Ion-Selective Electrode technology. All the investigations were done on ABBOTT c4000 fully automatic clinical chemistry analyzer.
Results: Most of the patients in our study were ≥50 years of age having posterior subcapsular cataract. The mean levels of serum fasting blood sugar (mg/dL), serum sodium (mmol/L), serum potassium (mmol/L) and serum calcium (mg/dL) were 99.4 ± 7.7; 140.4 ± 2.5; 4.2 ± 0.5; and 8.9 ± 0.5, respectively, in cases compared to 107.7 ± 12.3; 142.9 ± 5.0; 3.8 ± 0.5; and 8.3 ± 1.7, respectively, in healthy controls. A significantly higher number of cataract cases had elevated serum glucose and sodium levels, low serum potassium and calcium levels compared to healthy controls.
Conclusions: Hyperglycemia, hypernatremia, hypokalemia and hypocalcemia can independently increase the patients’ risk to cataracts. Corrections in these biochemical parameters may reduce cataract incidence.
Keywords: Blood pressure, Blood sugar, Calcium, Cataract, Intraocular pressure, Potassium, Sodium
Received: August 3, 2022
Accepted: December 21, 2022
Published online: January 16, 2023
Journal of Circulating Biomarkers - ISSN 1849-4544 - www.aboutscience.eu/jcb
© 2023 The Authors. This article is published by AboutScience and licensed under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).
Commercial use is not permitted and is subject to Publisher’s permissions. Full information is available at www.aboutscience.eu
Introduction
The International Agency for the Prevention of Blindness has defined cataract as the clouding or opacification of the normally clear lens of the eye or its capsule that obscures the passage of light through the lens to the retina (1,2). This disease, which can significantly reduce patient’s quality of life, is still one of the main ophthalmic public health conditions in developed and developing countries (3). Cataracts are mainly divided into nuclear cataract (NC), cortical cataract (CC), posterior sub capsular (PSC) cataract, acquired cataract and congenital cataract (4). Senile cataract is one of the common types of acquired cataract which occurs as a consequence of the aging process. It is characterized by initial opacity in the lens with subsequent swelling of lens and final shrinkage with complete loss of transparency (5). Cataract is detected by an eye examination that includes a visual activity test, slit lamp exam (SLE) and dilated eye exam (6).
Worldwide, cataract has caused >50% vision loss including 33.4% blind people and 18.4% people with moderate to severe visual impairment. Globally 10.8 million people were blind and 35.1 million people were visually impaired from cataract in 2010 (7). Additionally, data from the World Health Organization (WHO) has estimated that this number will increase to 40 million in 2025 due to the aging populations with greater life expectancies (8). Up to 50 million people in the world suffer from senile cataract (9,10), and its prevalence in developing countries is much more than in developed ones (11). In India, the prevalence of blindness due to cataract was reported to be 8% in the age group of >50 years, as per the National blindness survey (12). An estimated 20 lakh new cases of cataract are being added to the burden every year in this country, showing a steep rise ranging from 0.5% above 30 years to 94.5% above 70 years (13). Cataract accounts for 62.6% of all blindness, affecting 9-12 million bilaterally blind persons (14). The WHO/NPCB (National Programme for Control of Blindness) survey has shown that there are over 22 million blind in India and 80.1% of these are blind due to cataract (15).
Cataract is caused by degeneration and opacification of the lens fibers already formed. Any factor that disturbs the critical intra- and extracellular equilibrium of water and electrolytes or deranges the colloid system within the fibers tends to bring about opacification (16). Several studies have been carried out to elucidate risk factors which are responsible for development of cataract. Extensive research has established age, ion imbalance, altered calcium levels, diabetes and UV light exposure as causative risk factors for cataract, while recent studies have identified other potential risk factors like exogenous estrogen, nutrition, dietary fat and genetics which might play a role in the development of cataract (17). Although cataract affects all age groups its incidence increases with advancing age (18). Senile cataract affects equally persons of either gender, usually above the age of 50 years (19). The association between diabetes and cataract formation has been shown in clinical, epidemiological and basic research studies. Due to increasing numbers of type 1 and type 2 diabetics worldwide, the incidence of diabetic cataracts steadily rises (20). Several clinical studies have shown that cataract development occurs more frequently and at an earlier age in diabetic compared to nondiabetic patients (20). Many studies have shown that serum electrolyte (potassium and sodium) concentration directly affects the concentration of electrolytes in aqueous humor and thereby induces cataract formation. Concentration of sodium in lens is less compared to serum concentrations whereas it is vice versa in case of potassium concentrations, and this cationic balance is maintained by the osmotic pressure and thus water balance by the action of enzyme Na+/K+ ATPase. Any imbalance in between the electrolytes leads to cataract formation (21). Calcium is of particular concern in cataract. This cation is essential for various lens fiber cell metabolism processes (22). It has been shown that lens calcium content correlates with opacity in cataractous human lenses (23) and subsequent changes in serum calcium concentration might be an important factor in the development of cataract (24).
Demographic and clinico-biochemical biomarkers have been previously linked with the development of cataract from other parts of the world, but so far only few studies have been reported from the Indian subcontinent regarding the interrelationship of cataract (25,26). Keeping in view the ethnicity and relatively conserved genetic pool of Kashmiri population, this case-control study was designed to elucidate the role of demographic and clinico-biochemical parameters in the etiopathogenesis and severity of cataract in Kashmiri population.
Materials and methods
Ethics
This study was performed in line with the principles of the Declaration of Helsinki. Ethical clearance for the study was sought from Institutional Review Board, Government of Medical College Srinagar vide No. 2022T/ETH/GMC. All the patients included in the study were informed about the study and informed consent both in vernacular as well as in English language was taken before eliciting history and sample collection from study subjects. Standard questionnaire or patient proforma was properly recorded and drafted as per socio-demographic and clinico-biochemical parameters. The authors affirm that human research participants provided informed consent for publication of their details.
Study design
This was a case-control study conducted by the Department of Biochemistry in collaboration with the Department of Ophthalmology, Government Medical College Srinagar and associated SMHS hospital Srinagar, J&K, from March 2020 to March 2022.
Study subjects and sample size
The study was conducted in ethnic population of Kashmir; no restrictions were made among patients with respect to gender and dwelling. A total of 300 patients diagnosed with cataract and 360 healthy controls were enrolled for the study. Keeping the power of study as 80% and allocation ratio of 1.2 and effect size of 0.4, the sample size was calculated by G power 23.0.1 version.
Inclusion and exclusion criteria
“Cases” included all those individuals who were >18 years of age and diagnosed with cataract. “Cases” excluded all those individuals with any other eye ailment and symptomatic disease (liver, kidney, heart or other), trauma, infection, inflammation of eye, cancer or any other genetic abnormality. “Controls” included healthy individuals >18 years of age.
Ophthalmic examination
Each patient was subjected to various ophthalmic measurements. Uncorrected visual acuity was measured with Snellen chart. Refraction was done and the best corrected visual acuity was noted. Intraocular pressure (IOP) measurement was done with non-contact tonometer. Corrected IOP was calculated after measuring central corneal thickness by ultrasonic pachymetry. Detailed anterior segment examination using slit lamp was done to rule glaucoma and associated ocular pathology. Detailed fundus examination under full mydriasis obtained by 0.8% tropicamide and 5% phenylephrine was done with direct ophthalmoscopy, 78D and indirect ophthalmoscopy.
Sample collection
A total of 04 mL of venous blood was collected from each cataract patient and healthy control in a coagulation activating red top vial. Blood was collected from each individual after 8-10 hours of fasting. Blood was immediately centrifuged for separation of serum. Serum was properly stored at ‒20°C till biochemical analysis was done in the Biochemistry diagnostic laboratory, SMHS hospital Srinagar.
Biochemical analysis for electrolytes
Serum electrolyte levels were estimated on ABBOTT ARCHITECT c4000 fully automated clinical chemistry analyzer using Ion-Selective Electrode. The reference ranges of serum sodium levels were taken between 135 and 145 mmol/L and serum potassium levels as 3.5-4.5 mmol/L.
Biochemical analysis for calcium
Serum calcium levels were estimated spectrophotometrically on ABBOTT ARCHITECT c4000 fully automated clinical chemistry analyzer using Arsenazo III dye. The reference ranges of serum calcium were taken as: 8.5-10.2 mg/dL.
Biochemical analysis of glucose
Serum glucose levels were measured spectrophotometrically on ABBOTT ARCHITECT c4000 fully automated clinical chemistry analyzer. Glucose is phosphorylated by hexokinase (HK) in the presence of adenosine triphosphate (ATP) and magnesium ions to produce glucose-6-phosphate (G6P) and adenosine diphosphate (ADP). Glucose-6-phosphate dehydrogenase (G6PDH) specifically oxidizes G6P to 6-phosphogluconate with the concurrent reduction of nicotinamide adenine dinucleotide (NAD) and readily to nicotinamide adenine dinucleotide reduced (NADH). One micromole of NADH is produced for each micromole of glucose consumed. The NADH produced absorbs light at 340 nm and can be detected spectrophotometrically as an increased absorbance. The reference ranges of serum glucose were taken as: 99-100 mg/dL (normal) and >100 mg/dL (impaired).
Statistical analysis
The data was analyzed using IBM Statistical Package for the Social Sciences (SPSS) software v. 25.0. Descriptive statistics was performed and data was presented as frequency (N) and percentage (%). Continuous data was presented as mean and standard deviation. Chi-square test was used to compare proportions between groups as deemed proper by the statistical expert. P value <0.05 was considered statistically significant.
Results
Table I contains the socio-demographic and clinicopathological characteristics of cataract cases and healthy controls. Cases and controls were matched with respect to age and gender; 17.5% (63 of 360) of the controls were <50 years of age as compared to 21% (63 of 300) of cases who were <50 years of age. With respect to gender, 47.5% (171 of 360) controls were men as compared to 52.0% (156 of 300) of men having cataract. Accordingly, 90.0% (324 of 360) of the controls were inhabitants of rural areas as compared to 80% (240 of 300) of cases who belonged to rural areas. The cataract patients were evaluated for various clinical parameters. Hypertension was present in 13.0% (39 of 300) of cataract patients. The family history of cataract was present in 4.0% (12 of 300) of cases. The history of any other eye disorder was present in 23.0% (69 of 300) of cataract cases. Further the IOP of all the patients was measured wherein 91.0% (273 of 300) had normal IOP while 9.0% (27 of 300) had higher IOP.
– | Controls
N = 360 (%) |
Cases
N = 300 (%) |
χ2 | p value |
---|---|---|---|---|
Age group | ||||
<50 years
≥50 years |
63 (17.5)
297 (82.5) |
63 (21.0)
237 (79.0) |
1.2 | 0.15 |
Gender | ||||
Men
Women |
171 (47.5)
189 (52.5) |
156 (52.0)
144 (48.0) |
1.3 | 0.15 |
Dwelling | ||||
Rural
Urban |
324 (90.0)
36 (10.0) |
240 (80.0)
60 (20.0) |
13.1 | <0.0001 |
Hypertension | ||||
No
Yes |
– | 261 (87.0)
39 (13.0) |
– | – |
Family history of cataract | ||||
No
Yes |
– | 288 (96.0)
12 (4.0) |
– | – |
H/o any other eye disorder | ||||
No
Yes |
– | 231 (77.0)
69 (23.0) |
– | – |
Eyes affected | ||||
One
Both |
– | 177 (59.0)
123 (41.0) |
– | – |
Type of cataract | ||||
Nuclear
Cortical Posterior subcapsular |
– | 00 (0.0)
75 (25.0) 225 (75.0) |
– | – |
Grade | ||||
I and II
III and IV |
– | 165 (55.0)
135 (45.0) |
– | – |
IOP | ||||
Normal
High |
– | 273 (91.0)
27 (9.0) |
– | – |
H/o = history of; IOP = intraocular pressure.
Table II depicts the biochemical parameters of cataract cases and healthy controls; 69.0% (207 of 300) of cases had impaired blood sugar level as compared to 22.5% (81 of 360) of controls having impaired blood sugar, and the association was found to be statistically significant (p<0.0001); 36.3% (109 of 300) of cases had hypernatremia as compared to only 3.0% (11 of 360) of controls with hypernatremia (p<0.0001). Cataract cases had significantly low potassium levels compared to controls (17.5% vs. 6.1%; p<0.0001). In addition, 38.0% (114 of 300) of cases had hypocalcemia as compared to only 12.5% (45 of 360) of controls with hypocalcemia and the difference was statistically significant (p<0.0001).
Parameters | Controls
N = 360 (%) |
Cases
N = 300 (%) |
OR (95% CI) | p value |
---|---|---|---|---|
Fasting blood sugar | ||||
Normal
Impaired |
279 (77.5)
81 (22.5) |
93 (31.0)
207 (69.0) |
7.6 (5.4-10.8) | <0.0001 |
Sodium levels | ||||
Normal
High |
349 (97.0)
11 (3.0) |
191 (63.7)
109 (36.3) |
18.1 (9.5-34.4) | <0.0001 |
Potassium levels | ||||
Normal
Low |
338 (93.9)
22 (6.1) |
249 (83.0)
51 (17.0) |
3.1 (1.9-5.3) | <0.0001 |
Calcium levels | ||||
Normal
Low |
315 (87.5)
45 (12.5) |
186 (62.0)
114 (38.0) |
4.2 (2.9-6.3) | <0.0001 |
CI = confidence interval; OR = odds ratio.
Table III shows the mean levels of various biochemical parameters in cases and healthy controls. A statistically significant difference was observed between cases and controls with respect to mean fasting blood sugar levels in mg/dL (107.7 ± 12.3 vs. 99.4 ± 7.7); mean sodium levels in mmol/L (142.9 ± 5.0 vs. 140.4 ± 2.5); mean potassium level in mmol/L (3.8 ± 0.5 vs. 4.2 ± 0.5); mean calcium level in mg/dL (8.3 ± 1.7 vs. 8.9 ± 0.5).
Parameters | Controls
(mean ± SD) |
Cases
(mean ± SD) |
p value |
---|---|---|---|
Fasting blood sugar (mg/dL) | 99.4 ± 7.7 | 107.7 ± 12.3 | <0.0001 |
Sodium levels (mmol/L) | 140.4 ± 2.5 | 142.9 ± 5.0 | <0.0001 |
Potassium levels (mmol/L) | 4.2 ± 0.5 | 3.8 ± 0.5 | <0.0001 |
Calcium levels (mg/dL) | 8.9 ± 0.5 | 8.3 ± 1.7 | <0.0001 |
SD = standard deviation.
Table IV shows the association of fasting blood sugar levels with various socio-demographic, clinico-pathological and biochemical parameters of cataract patients and controls. In each subgroup of age, gender, dwelling, sodium, potassium and calcium levels, a statistically significant difference in serum blood levels was noted between cases and controls (p<0.0001). Among patients with PSC cataract, 72.0% (162 of 225) had impaired blood sugar level as compared to CC wherein only 60% (45 of 75) had impaired blood sugar, and the difference was statistically significant (p = 0.05). No association was found between blood sugar levels and any other parameter of cases and controls.
Table V describes the association of serum sodium levels with various socio-demographic, biochemical and clinicopathological parameters of cataract cases and controls. A statistically significant difference in serum sodium levels was noted between cases and controls in each subgroup of age, gender, dwelling, potassium and calcium levels (p<0.0001). Among cataract patients with grade I and II disease, 41.2% (68 of 165) had high sodium levels while among cataract patients with grade III and IV disease, only 30.4% (41 of 135) had high sodium levels and the difference was statistically significant (p = 0.05). We did not observe any other parameter influencing the sodium levels in cataract patients.
Table VI displays the association of serum potassium levels with various socio-demographic, clinicopathological and biochemical parameters of cataract patients and controls. Among cases, 20% (48 of 240) of rural inhabitants had low potassium levels as compared to 6.5% (21 of 324) of rural control subjects having low potassium levels (p<0.0001). With respect to calcium level, 31.6% (36 of 114) of hypocalcemia cases had hypokalemia as compared to only 2.2% (01 of 45) of hypocalcemia controls having hypokalemia, and the difference was statistically significant (p<0.0001). Among hypertensive cases, 15.4% (18 of 39) had hypokalemia but among normotensive cases only 12.6% (21 of 261) had hypokalemia, and the difference was statistically significant (p<0.0001). Importantly, 33.3% (09 of 27) cases having high IOP were hypokalemic but among cases having normal IOP, only 15.4% (42 of 273) had hypokalemia, and the difference was statistically significant (p<0.0001). No association was found between serum potassium levels and any other parameter of cases and controls.
Table VII depicts the association of serum calcium levels with various socio-demographic, clinicopathological and biochemical parameters of cataract cases and controls. A statistically significant difference in calcium levels was noted between cases and controls in each subgroup of age, gender and dwelling (p<0.0001). We did not observe any other parameter influencing the calcium levels in cataract patients.
Discussion
We evaluated cataract patients with respect to various socio-demographic, clinicopathological and biochemical characteristics. As aging itself is a major risk factor for the development of cataract in both women and men (27), most of the cataract patients were from the age group of ≥50 years. It has been suggested that with aging the alteration in membrane permeability of the lens epithelium coupled with the changes in sodium and potassium ion levels in aqueous humor may accentuate ionic imbalance within the lens and lead to the development of cataract (28). In our study, a slightly higher percentage of men population was affected compared to women. According to different studies, women are more prone to getting most types of cataract than men. This is most likely due to lower estrogen levels after menopause in women (29). In our study, proportion of rural participants diagnosed with cataract was much higher compared to urban participants, which may be due to the differential exposure to contextual factors (30). Furthermore, we speculate that rural areas lack quality healthcare and hygiene, hence putting inhabitants at more risk of developing cataract and its related complications. Our results are in line with the observations from other parts of the country reporting significantly higher incidence of cataract in rural areas (31). We observed only 13.0% of the cataract cases to be hypertensive, but according to Lee et al hypertension could induce conformational changes to proteins in lens capsules, thereby exacerbating the cataract formation (32). Per previous reports, the risk of cataract increases with long-standing hypertension (33). Furthermore, some studies suggest that antihypertensive medications (such as diuretics and beta-blockers) are related to cataract (34). In our study, only few cataract patients had a family history of cataract. Our findings are consistent with epidemiological studies demonstrating more prevalent occurrence of age-related cataracts in close relatives of cataract patients than in the general population (35). In addition, genetic studies have shown the effect of specific genes in the development of cataractous lenses (35). Only one eye was affected in most of the cataract patients, which supports the previous findings that cataract may be present in one or both eyes but cannot spread from one eye to another (36). Most of the enrolled patients were having PSC cataract, which is the most common morphological form of cataract (37) and commonly studied across the country (38). PSC cataract produces more and faster vision deterioration than other forms of cataract, and patients report earlier for cataract surgery, which may be a potential explanation for its elevated prevalence (39).
Socio-demographic/clinicopathological/biochemical parameters | Fasting serum glucose levels in controls | Fasting serum glucose levels in cases | OR (95% CI) | p value | ||||
---|---|---|---|---|---|---|---|---|
N = 360 (%) | Normal
279 (77.5) |
Impaired
81 (22.5) |
N = 300 (%) | Normal
93 (31.0) |
Impaired
207 (69.0) |
7.6 (5.4-10.8) | <0.0001 | |
Age group | ||||||||
<50 years
≥50 years |
63 (17.5)
297 (82.5) |
57 (90.5)
222 (74.7) |
06 (9.5)
75 (25.3) |
63 (21.0)
237 (79.0) |
17 (27.0)
76 (32.1) |
46 (73.0)
161 (67.9) |
25.7 (9.3-70.4)
6.2 (4.2-9.1) |
<0.0001
<0.0001 |
Gender | ||||||||
Men
Women |
171 (47.5)
189 (52.5) |
141 (82.5)
138 (73.0) |
30 (17.5)
51 (27.0) |
156 (52.0)
144 (48.0) |
48 (30.8)
45 (31.3) |
108 (69.2)
99 (68.8) |
10.5 (6.2-17.7)
5.9 (3.6-9.5) |
<0.0001
<0.0001 |
Dwelling | ||||||||
Rural
Urban |
324 (90.0)
36 (10.0) |
255 (78.7)
24 (66.7) |
69 (21.3)
12 (33.3) |
240 (80.0)
60 (20.0) |
75 (31.3)
18 (30.0) |
165 (68.8)
45 (70.0) |
8.1 (5.5-11.9)
4.6 (1.9-11.3) |
<0.0001
<0.001 |
Sodium levels | ||||||||
Normal
Elevated |
349 (97.0)
11 (3.0) |
270 (77.4)
09 (81.8) |
79 (22.6)
02 (18.2) |
191 (63.7)
109 (36.3) |
58 (30.4)
35 932.1) |
133 (69.6)
74 (67.9) |
7.8 (5.2-11.6)
9.5 (1.9-46.3) |
<0.0001
0.002 |
Potassium levels | ||||||||
Normal
Low |
338 (93.9)
22 (6.1) |
261 (77.2)
18 (81.8) |
77 (22.8)
04 (18.2) |
249 (83.0)
51 (17.0) |
84 (33.7)
09 (17.6) |
165 (66.3)
42 (82.4) |
6.6 (4.6-9.5)
21 (5.7-77.1) |
<0.0001
<0.0001 |
Calcium levels | ||||||||
Normal
Low |
315 (87.5)
45 (12.5) |
246 (78.1)
33 (73.3) |
69 (21.9)
12 (26.7) |
186 (62.0)
114 (38.0) |
60 (32.3)
33 (28.9) |
126 (67.7)
81 (71.1) |
7.4 (4.9-11.2)
6.7 (3.1-14.6) |
<0.0001
<0.0001 |
Hypertension | ||||||||
No
Yes |
– | – | – | 261 (87.0)
39 (13.0) |
78 (29.9)
15 (38.5) |
183 (70.1)
24 (61.5) |
0.6 (0.3-1.3) | 0.3 |
Family history of cataract | ||||||||
No
Yes |
– | – | – | 288 (96.0)
12 (4.0) |
84 (29.2)
009 (75.0) |
204 (70.8)
03 (25.0) |
0.13 (0.03-0.5) | 0.002 |
H/o any other eye disorder | ||||||||
No
Yes |
– | – | – | 231 (77.0)
69 (23.0) |
72 (31.2)
21 (30.4) |
159 (68.8)
48 (69.6) |
1.03 (0.5-1.8) | 1.000 |
Eyes affected | ||||||||
One
Both |
– | – | – | 177 (59.0)
123 (41.0) |
57 (32.2)
36 (29.3) |
120 (67.8)
87 (70.7) |
1.1 (0.6-1.8) | 0.6 |
Type of cataract | ||||||||
Cortical
Posterior subcapsular |
– | – | – | 75 (25.0)
225 (75.0) |
30 (40.0)
63 (28.0) |
45 (60.0)
162 (72.0) |
1.7 (0.9-2.9) | 0.05 |
Grade | ||||||||
I and II
III and IV |
– | – | – | 165 (55.0)
135 (45.0) |
45 (27.3)
48 (35.6) |
120 (72.7)
87 (64.4) |
0.6 (0.4-1.1) | 0.1 |
IOP | ||||||||
Normal
High |
– | – | – | 273 (91.0)
27 (9.0) |
81 (29.7)
12 (44.4) |
192 (70.3)
15 (55.6) |
0.5 (0.2-1.1) | 0.12 |
CI = confidence interval; H/o = history of; IOP = intraocular pressure; OR = odds ratio.
Socio-demographic/clinicopathological/biochemical parameters | Serum sodium levels in controls | Serum sodium levels in cases | OR (95% CI) | p value | ||||
---|---|---|---|---|---|---|---|---|
N = 360 (%) | Normal
349 (97.0) |
High
11 (3.0) |
N = 300 (%) | Normal
191 (63.7) |
High
109 (36.3) |
18.1 (9.5 -34.4) | <0.0001 | |
Age group | ||||||||
<50 years
≥50 years |
63 (17.5)
297 (82.5) |
63 (100.0)
286 (96.3) |
0 (0.0)
11 (3.7) |
63 (21.0)
237 (79.0) |
25 (39.7)
166 (70.0) |
38 (60.3)
71 (30.0) |
–
11.1 (5.7-21.5) |
<0.0001
<0.0001 |
Gender | ||||||||
Men
Women |
171 (47.5)
189 (52.5) |
162 (94.7)
187 (98.9) |
09 (5.3)
02 (1.1) |
156 (52.0)
144 (48.0) |
99 (63.5)
92 (63.9) |
57 (36.5)
52 (36.1) |
10.3 (4.9-21.8)
52.8 (12.5-221.7) |
<0.0001
<0.0001 |
Dwelling | ||||||||
Rural
Urban |
324 (90.0)
36 (10.0) |
314 (96.9)
35 (97.2) |
10 (3.1)
01 (2.8) |
240 (80.0)
60 (20.0) |
150 (62.5)
41 (68.3) |
90 (37.5)
19 (31.7) |
18.8 (9.5-37.2)
16.2 (2.0-127.3) |
<0.0001
<0.0001 |
Potassium levels | ||||||||
Normal
Low |
338 (93.9)
22 (6.1) |
329 (97.3)
20 (90.9) |
09 (2.7)
02 (9.1) |
249 (83.0)
51 (17.0) |
162 (65.1)
29 (56.9) |
87 (34.9)
22 (43.1) |
19.6 (9.6-39.9)
7.1 (3.8-13.3) |
<0.0001
<0.0001 |
Calcium levels | ||||||||
Normal
Low |
315 (87.5)
45 (12.5) |
304 (96.5)
45 (100.0) |
11 (3.5)
00 (0.0) |
186 (62.0)
114 (38.0) |
121 (61.5)
70 (61.4) |
65 (34.9)
44 (38.6) |
14.8 (7.5-29.0)
– |
<0.0001
<0.0001 |
Hypertension | ||||||||
No
Yes |
– | – | – | 261 (87.0)
39 (13.0) |
165 (63.2)
26 (66.7) |
96 (36.8)
13 (33.3) |
0.9 (0.4-1.7) | 0.7 |
Family history of cataract | ||||||||
No
Yes |
– | – | – | 288 (96.0)
12 (4.0) |
184 (63.9)
07 (58.3) |
104 (36.1)
05 (41.7) |
1.2 (0.3-4.0) | 0.7 |
H/o any other eye disorder | ||||||||
No
Yes |
– | – | – | 231 (77.0)
69 (23.0) |
153 (66.2)
38 (55.1) |
78 (33.8)
31 (44.9) |
1.6 (0.9-2.7) | 0.11 |
Eyes affected | ||||||||
One
Both |
– | – | – | 177 (59.0)
123 (41.0) |
119 (67.2)
72 (58.5) |
58 (32.8)
51 (41.5) |
1.4 (0.9-2.3) | 0.14 |
Type of cataract | ||||||||
Cortical
Posterior subcapsular |
– | – | – | 75 (25.0)
225 (75.0) |
53 (70.6)
138 (61.3) |
22 (29.3)
87 (38.6) |
1.5 (0.8-2.6) | 0.16 |
Grade | ||||||||
I and II
III and IV |
– | – | – | 165 (55.0)
135 (45.0) |
97 (58.8)
94 (69.6) |
68 (41.2)
41 (30.4) |
0.6 (0.3-1.0) | 0.052 |
IOP | ||||||||
Normal
High |
– | – | – | 273 (91.0)
27 (9.0) |
175 (64.1)
16 (59.3) |
98 (35.9)
11 (40.7) |
1.2 (0.5-2.7) | 0.6 |
CI = confidence interval; H/o = history of; IOP = intraocular pressure; OR = odds ratio.
Socio-demographic/clinicopathological/biochemical parameters | Serum potassium levels in controls | Serum potassium levels in cases | OR (95% CI) | p value | ||||
---|---|---|---|---|---|---|---|---|
N = 360 (%) | Normal
338 (93.9) |
Low
22 (6.1) |
N = 300 (%) | Normal
249 (83.0) |
Low
51 (17.0) |
3.1 (1.9-5.3) | <0.0001 | |
Age group | ||||||||
<50 years
≥50 years |
63 (17.5)
297 (82.5) |
62 (98.4)
276 (92.9) |
01 (1.6)
21 (7.1) |
63 (21.0)
237 (79.0) |
48 (76.2)
201 (84.8) |
15 (23.8)
36 (15.2) |
19.3 (2.4-151.8)
2.3 (1.3-4.1) |
<0.0001
<0.0003 |
Gender | ||||||||
Men
Women |
171 (47.5)
189 (52.5) |
163 (95.3)
175 (92.6) |
08 (4.7)
14 (7.4) |
156 (52.0)
144 (48.0) |
132 (84.6)
117 (7.4) |
24 (15.4)
27 (18.8) |
3.7 (1.6-8.5)
2.8 (1.4-5.7) |
<0.0001
<0.0002 |
Dwelling | ||||||||
Rural
Urban |
324 (90.0)
36 (10.0) |
303 (93.5)
35 (97.2) |
21 (6.5)
01 (2.8) |
240 (80.0)
60 (20.0) |
192 (80.0)
57 (95.0) |
48 (20.0)
03 (5.0) |
3.6 (2.0-6.2)
1.8 (0.1-18.4) |
<0.0001
1.000 |
Calcium levels | ||||||||
Normal
Low |
315 (87.5)
45 (12.5) |
294 (93.3)
44 (97.8) |
21 (6.7)
01 (2.2) |
186 (62.0)
114 (38.0) |
171 (91.9)
78 (68.4) |
15 (8.1)
36 (31.6) |
1.2 (0.6-2.4)
20.3 (2.6-153.2) |
0.6
<0.0001 |
Hypertension | ||||||||
No
Yes |
– | – | – | 261 (87.0)
39 (13.0) |
228 (87.4)
33 (84.6) |
21 (12.6)
18 (15.4) |
5.9 (2.8-12.2) | <0.0001 |
Family history of cataract | ||||||||
No
Yes |
– | – | – | 288 (96.0)
12 (4.0) |
240 (83.3)
09 (75.0) |
48 (16.7)
03 (25.0) |
1.6 (0.4-6.3) | 0.4 |
H/o any other eye disorder | ||||||||
No
Yes |
– | – | – | 231 (77.0)
69 (23.0) |
195 (84.4)
54 (78.3) |
36 (15.6)
15 (21.7) |
1.5 (0.7-2.9) | 0.27 |
Eyes affected | ||||||||
One
Both |
– | – | – | 177 (59.0)
123 (41.0) |
150 (84.7)
99 (80.5) |
27 (15.3)
24 (19.5) |
1.3 (0.7-2.4) | 0.35 |
Type of cataract | ||||||||
Nuclear
Cortical Posterior subcapsular |
– | – | – | 75 (25.0)
225 (75.0) |
57 (76.0)
192 (85.3) |
18 (24.0)
33 (14.7) |
0.5 (0.2-1.0) | 0.07 |
Grade | ||||||||
I and II
III and IV |
– | – | – | 165 (55.0)
135 (45.0) |
132 (80.0)
117 (86.7) |
33 (20.0)
18 (13.3) |
0.6 (0.3-1.1) | 0.16 |
IOP | ||||||||
Normal
High |
– | – | – | 273 (91.0)
27 (9.0) |
231 (84.6)
18 (66.7) |
42 (15.4)
09 (33.3) |
2.7 (1.1-6.5) | 0.051 |
CI = confidence interval; H/o = history of; IOP = intraocular pressure; OR = odds ratio.
Socio-demographic/clinicopathological/biochemical parameters | Serum calcium levels in controls | Serum calcium levels in cases | OR (95% CI) | p value | ||||
---|---|---|---|---|---|---|---|---|
N = 360 (%) | Normal
315 (87.5) |
Low
45 (12.5) |
N = 300 (%) | Normal
186 (62.0) |
Low
114 (38.0) |
4.2 (2.9-6.3) | <0.0001 | |
Age group | ||||||||
<50 years
≥50 years |
63 (17.5)
297 (82.5) |
54 (85.7)
261 (81.7) |
09 (14.3)
36 (12.1) |
63 (21.0)
237 (79.0) |
40 (63.5)
146 (61.6) |
23 (36.5)
91 (38.4) |
3.4 (1.4-8.2)
4.5 (2.9-6.9) |
0.007
<0.0001 |
Gender | ||||||||
Men
Women |
171 (47.5)
189 (52.5) |
147 (86.0)
168 (88.9) |
24 (14.0)
21 (11.1) |
156 (52.0)
144 (48.0) |
96 (61.5)
90 (62.5) |
60 (38.5)
54 (37.5) |
3.8 (2.2-6.5)
4.8 (2.7-8.4) |
<0.0001
<0.0001 |
Dwelling | ||||||||
Rural
Urban |
324 (90.0)
36 (10.0) |
282 (87.0)
33 (91.7) |
42 (13.0)
03 (8.3) |
240 (80.0)
60 (20.0) |
144 (60.0)
42 (70.0) |
96 (40.0)
18 (30.0) |
4.4 (2.9-6.7)
4.7 (1.2-17.3) |
<0.0001
0.02 |
Hypertension | ||||||||
No
Yes |
– | – | – | 261 (87.0)
39 (13.0) |
168 (64.4)
18 (46.2) |
93 (35.6)
21 (53.8) |
2.1 (1.0-4.1) | 0.3 |
Family history of cataract | ||||||||
No
Yes |
– | – | – | 288 (96.0)
12 (4.0) |
180 (62.5)
06 (50.0) |
108 (37.5)
06 (50.0) |
1.6 (0.5-5.2) | 0.3 |
H/o any other eye disorder | ||||||||
No
Yes |
– | – | – | 231 (77.0)
69 (23.0) |
147 (63.6)
39 (56.5) |
84 (36.4)
30 (43.5) |
1.3 (0.7-2.3) | 0.3 |
Eyes affected | ||||||||
One
Both |
– | – | – | 177 (59.0)
123 (41.0) |
114 (64.4)
72 (58.5) |
63 (35.6)
51 (41.5) |
1.2 (0.7-2.0) | 0.3 |
Type of cataract | ||||||||
Nuclear
Cortical Posterior subcapsular |
– | – | – | 75 (25.0)
225 (75.0) |
51 (68.0)
135 (60.0) |
24 (32.0)
90 (40.0) |
1.4 (0.8-2.4) | 0.2 |
Grade | ||||||||
I and II
III and IV |
– | – | – | 165 (55.0)
135 (45.0) |
99 (60.0)
87 (64.4) |
66 (40.0)
48 (35.6) |
0.8 (0.5-1.3) | 0.4 |
IOP | ||||||||
Normal
High |
– | – | – | 273 (91.0)
27 (9.0) |
171 (62.6)
15 (55.6) |
102 (37.4)
12 (44.4) |
1.3 (0.6-2.9) | 0.5 |
CI = confidence interval; H/o = history of; IOP = intraocular pressure; OR = odds ratio.
Various studies are going on all over the world to clarify the relationship between biochemical elements and cataract formation (40), and most of the studies from different populations have not found a remarkable difference in blood biochemical elements between cataract patients and healthy controls (41-43). To further explore the biochemical intricacies of cataract we evaluated the cases as well as controls for various biochemical markers and deduced the relationship, if any, between the disease development and biochemical markers. As evident from the dataset, most of the cataract patients in our study were having significantly impaired fasting blood sugar levels compared to controls. A previous study has found a significant relationship between hyperglycemia and incidence of cataracts (44). In vivo or in vitro studies showed evidence that diabetes mellitus is the cause of cataract (45,46). Cataracts have multiple etiologies, one of which is chronic hyperglycemia which has been related to many systemic and ocular complications such as loss of vision. It has been suggested that the polyol via which the enzyme aldose reductase catalyzes the reduction of glucose into sorbitol is a central part of the mechanism of cataract development. The increased intracellular accumulation of sorbitol leads to a hyperosmotic effect, resulting in hydropic lens fibers that degenerate and form cataract (47,48). In our study population, the frequency of cataract patients having hypernatremia was significantly higher compared to controls, which is in line with the study conducted by Mathur and Pai who reported significant hypernatremia in cataract patients compared to the controls (49). Since the lens metabolism is associated with aqueous humor, which itself is produced from blood secretions, serum electrolyte concentration directly affects electrolytes of aqueous humor and in turn lens metabolism (26). Studies have upheld that, in case of increased concentrations of sodium in aqueous humor, it is difficult for the sodium pumps to maintain a low intracellular sodium ion level. In turn, a higher sodium ion concentration of the aqueous humor, coupled with an altered membrane permeability of lens, increases the intracellular sodium ion concentration leading to hydration of the lens, thereby resulting in loss of its transparency and development of cataract (50). In the current study, we observed hypokalemia in significantly higher number of cataract patients compared to controls. Several studies revealed strong association of low serum potassium levels with CCs (51,52). According to Duncan and Bushell, cortical and mature cataracts had very low serum potassium levels (53). The frequency of hypocalcemia in cataract cases was significantly higher compared to controls. Low serum calcium levels in cataract patients were seen in other populations, clearly supporting our results (54). Cataract is the most common ocular symptom of hypocalcemia (55). Seemingly, because of deposition of calcium in soft tissues producing reduced vision/cataract or calcification of basal ganglia, calcium gets depleted in human serum (56).
In the further part of the study we deciphered the effect of various factors on the relationship between biochemical parameters and cataract. Surprisingly none of the factors significantly affected the relationship of serum glucose, serum sodium and serum calcium with cataract. In addition, we have also identified various factors modifying the association between hypokalemia and cataract. The frequency of hypokalemic rural cataract patients was significantly higher compared to rural hypokalemic controls. Difference in mean serum potassium concentrations among Kashmiri cataract cases and healthy controls residing in rural locations might be due to difference in the quality of diet among the two groups (56,57). Interestingly we observed a significantly higher proportion of hypokalemic cataract patients coexistent with hypocalcemia. Although hypokalemia and hypocalcemia exhibit multiple interrelated acid-base and electrolyte abnormalities such as hypophosphatemia, respiratory/metabolic alkalosis, mixed acid-base disorders (58), the coexistence of these in cataract has not yet been reported and debated upon. Further, hypokalemia was significantly associated with hypertension in cataract patients. Even though the association of hypokalemia and hypertension has been previously reported (33,34), the common causes of hypertension with hypokalemia have been well established, which include essential hypertension with diuretic use, primary aldosteronism, Cushing’s syndrome, pheochromocytoma, renal vascular disease and malignant hypertension (59). Therefore, patients with coexistent hypertension and hypokalemia need to be evaluated further to establish the reason for the development of cataract.
Conclusion
In conclusion, serum glucose, sodium, potassium and calcium levels were identified as the potentially modifiable parameters deranged in cataract. In future, large-scale studies to enhance the battery of biochemical markers and to establish cause and effect relationship between biochemical markers and cataract need to be done.
Limitation of the study
The sample size of the study is relatively modest.
Disclosures
Conflict of interest: The authors disclose that there are no financial or non-financial interests that are directly or indirectly related to the work submitted for publication.
Financial support: The study was funded by Government Medical College Srinagar, Karan Nagar, Srinagar, Jammu & Kashmir, India, vide GMC/2022/17.
Authors’/contributors’ list: Conceptualization: MSK, TR, SR; Data curation: MSK, SSA; Formal analysis: MSK, TR, SSA; Funding acquisition: TR, SM; Investigation: MSK, TR, SSA, RI; Methodology: RI; Project administration: SM, SR; Resources: SM; Software: MSK; Supervision: SM, SR; Validation: MSK, TR, SR; Visualization: MSK, RI; Writing—original draft: MSK, TR, RI; Writing-review and editing: MSK; Approval of final manuscript: all authors.
References
- 1. Nizami AA, Gulani AC. Cataract. 2022 Jul 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PubMed
- 2. Sayegh RR, Floyd RP, Ghanem RC, Azar DT. History of cataract surgery. In: Albert DM, Miller JW, Azar DT, Blodi BA, ed. Albert and Jakobiec’s principles and practice of ophthalmology. Philadelphia: Saunders 2008; 1,3. Online Accessed July 2022.
- 3. Cedrone C, Culasso F, Cesareo M, et al. Prevalence and incidence of age-related cataract in a population sample from Priverno, Italy. Ophthalmic Epidemiol. 1999 Jun;6(2):95-103. CrossRef PubMed
- 4. Types of Cataract. national Eye Institute. Online.
- 5. Milacic S. Risk of occupational radiation-induced cataract in medical workers. Med Lav. 2009;100(3):178-186. PubMed
- 6. Eye Exam: What to Expect. Online
- 7. Bourne RR, Stevens GA, White RA, et al; Vision Loss Expert Group. Causes of vision loss worldwide, 1990-2010: a systematic analysis. Lancet Glob Health. 2013;1(6):e339-e349. CrossRef PubMed
- 8. Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012 May;96(5):614-618. CrossRef PubMed
- 9. Bunce GE, Kinoshita J, Horwitz J. Nutritional factors in cataract. Annu Rev Nutr. 1990;10(1):233-254. CrossRef PubMed
- 10. Minassian DC, Mehra V. 3.8 million blinded by cataract each year: projections from the first epidemiological study of incidence of cataract blindness in India. Br J Ophthalmol. 1990;74(6):341-343. CrossRef PubMed
- 11. Sperduto RD. Epidemiological aspects of age related cataract. In: Tasman W, Jaeger A, eds. Duane’s clinical ophthalmology. Lippincott Raven Publishers 2000; 12-14.
- 12. National programme for control of Blindness in India, Directorate General of Health Sciences. Rapid Assessment of Avoidable Blindness New Delhi Ministry of Health and Femen Welfare, Government of India. Online
- 13. Soudarssanane MB, Bansal RD. Prevalence of senile cataract in a rural population in Pondicherry. Indian J Community Med. 1985;10(3):175-179. Online Accessed July 2022.
- 14. Murthy GV, Gupta SK, Bachani D, Jose R, John N. Current estimates of blindness in India. Br J Ophthalmol. 2005;89(3):257-260. CrossRef PubMed
- 15. Government of India. National survey on blindness and visual outcomes after cataract surgery. Dr. Rajendra Prasad Centre for Ophthalmic Sciences. New Delhi: All India Institute of Medical Sciences; 2001-2002. Online Accessed July 2022.
- 16. Sihota R, Tandon R. Parsons’ diseases of the eye, 23rd ed. Elsevier India 2019; 628. Online Accessed July 2022.
- 17. Garg P, Mullick R, Nigam B, Raj P. Risk factors associated with development of senile cataract. Ophthalmol J. 2020;5(0):17-24. CrossRef
- 18. Klein BE, Klein R, Linton KL. Prevalence of age-related lens opacities in a population. The Beaver Dam Eye Study. Ophthalmology. 1992;99(4):546-552. CrossRef PubMed
- 19. Bron AJ, Vrensen GF, Koretz J, Maraini G, Harding JJ. The ageing lens. Ophthalmologica. 2000;214(1):86-104. CrossRef
- 20. Stanga PE, Boyd SR, Hamilton AMP. Ocular manifestations of diabetes mellitus. Curr Opin Ophthalmol. 1999;10(6):483-489. CrossRef PubMed
- 21. Rewatkar M, Muddeshwar MG, Lokhande M, Ghosk K. Electrolyte imbalance in eyes of Indian cataract patients. Ind Med Gaz. 2012;10:89-91. Online
- 22. Seeman E. Pathogenesis of bone fragility in women and men. Lancet. 2002;359(9320):1841-1850. CrossRef PubMed
- 23. Hightower KR, Hind D. Cytotoxic effects of calcium on sodium-potassium transport in the mammalian lens. Curr Eye Res. 1982-1983;2(4):239-246. CrossRef PubMed
- 24. Mukai K, Matsushima H, Ishii Y, Obara Y. [Effects of calcium on lens epithelial cells in rabbits]. Nippon Ganka Gakkai Zasshi. 2006;110(5):361-369. PubMed
- 25. Chandorkar AG, Bulakh PM, Albal MV. Electrolyte composition in normal and cataractous lenses. Indian J Ophthalmol. 1980;28(3):135-138. PubMed
- 26. Bansal A, Amin H, Rekha R. Correlation of aqueous humor electrolytes with serum electrolytes in cataract patients. Indian J Ophthalmol. 2021;69(10):2675-2677. CrossRef PubMed
- 27. Gupta VB, Rajagopala M, Ravishankar B. Etiopathogenesis of cataract: an appraisal. Indian J Ophthalmol. 2014;62(2):103-110. CrossRef PubMed
- 28. Asbell PA, Dualan I, Mindel J, Brocks D, Ahmad M, Epstein S. Age-related cataract. Lancet. 2005;365(9459):599-609. CrossRef PubMed
- 29. Zetterberg M, Celojevic D. Gender and cataract—the role of estrogen. Curr Eye Res. 2015;40(2):176-190. CrossRef PubMed
- 30. Ndong AK, van der Linden EL, Beune EJAJ, et al. Serum potassium concentration and its association with hypertension among Ghanaian migrants and non-migrants: the RODAM study. Atherosclerosis. 2022;342:36-43. CrossRef PubMed
- 31. Singh S, Pardhan S, Kulothungan V, et al. The prevalence and risk factors for cataract in rural and urban India. Indian J Ophthalmol. 2019;67(4):477-483. CrossRef PubMed
- 32. Lee SM, Lin SY, Li MJ, Liang RC. Possible mechanism of exacerbating cataract formation in cataractous human lens capsules induced by systemic hypertension or glaucoma. Ophthalmic Res. 1997;29(2):83-90. CrossRef PubMed
- 33. Mukesh BN, Le A, Dimitrov PN, Ahmed S, Taylor HR, McCarty CA. Development of cataract and associated risk factors: the Visual Impairment Project. Arch Ophthalmol. 2006;124(1):79-85. CrossRef PubMed
- 34. Cumming RG, Mitchell P. Medications and cataract. The Blue Mountains Eye Study. Ophthalmology. 1998;105(9):1751-1758. CrossRef PubMed
- 35. Bamdad S, Shiraly R. Risk factors associated with cataracts in middle-aged people, an incidence-based case-control study in Shiraz, Iran. Shiraz E-Med J. 2019;20(9):1-7. CrossRef
- 36. Cataracts. John Hopkins Medicine. Online
- 37. Fekri Y, Ojaghi H, Moghadam TZ, Shargi A, Ranjbar A, Moghadam TZ. A study of morphology of cataract in surgery candidates in Ardabil: Iran. J Ardabil Univ Med Sci. 2020;20(1):127-136. Online Accessed July 2022.
- 38. Malhotra C, Dhingra D, Nawani N, Chakma P, Jain AK. Phacoemulsification in posterior polar cataract: experience from a tertiary eye care centre in North India. Indian J Ophthalmol. 2020;68(4):589-594. CrossRef PubMed
- 39. Garrigan H, Ifantides C, Prashanthi GS, Das AV. Biogeographical and altitudinal distribution of cataract: a nine-year experience using electronic medical record-driven big data analytics in India. Ophthalmic Epidemiol. 2021;5:392-399. CrossRef PubMed
- 40. Hassan H, Khaleel FM, Taee KA. Biochemical parameters determination for prognosis of retinal diseases and their relationship to cataract, diabetes and hypertension patients in Ibn Al-Haytham Hospital in Baghdad-Iraq. Neuroquantology. 2021;19(5):43-44. CrossRef
- 41. Ipchi SP, Mahboub S, Hassanzadeh D, Safaeian AR, Rashidi MR, Zareh A. Relationship between Serum Na+, Ca++ and K+ levels, nutritional status and senile cataract formation. Pharm Sci. 2001;4:1-8.
- 42. The Italian-American Cataract Study Group. Risk factors for age-related cortical, nuclear, and posterior subcapsular cataracts. Am J Epidemiol. 1991;133(6):541-553. PubMed
- 43. Mansoor A, Gul R, Malik TG, Khalil M, Alam R. Senile cataract patients; serum electrolytes and calcium. Prof Med J. 2015;22(9):1186-1191. CrossRef
- 44. Harahap J, Rania R. Cataracts Risk Factors and Comparison of Blood Glucose Levels in Diabetic and Non-Diabetic Patients towards the Occurrence of Cataracts. Open Access Maced J Med Sci. 2019 Oct 14;7(20):3359-3362. CrossRef PubMed PMCID: PMC6980819
- 45. Brian G, Taylor H. Cataract blindness—challenges for the 21st century. Bull World Health Organ. 2001;79(3):249-256. PubMed
- 46. Delcourt C, Carrière I, Ponton-Sanchez A, Lacroux A, Covacho MJ, Papoz L. Light exposure and the risk of cortical, nuclear, and posterior subcapsular cataracts: the Pathologies Oculaires Liées à l’Age (POLA) study. Arch Ophthalmol. 2000;118(3):385-392. CrossRef PubMed
- 47. Kador PF, Wyman M, Oates PJ. Aldose reductase, ocular diabetic complications and the development of topical Kinostat(®). Prog Retin Eye Res. 2016;54:1-29. CrossRef PubMed
- 48. Kinoshita JH. Mechanisms initiating cataract formation. Proctor Lecture. Invest Ophthalmol. 1974;13(10):713-724. PubMed
- 49. Mathur G, Pai V. Comparison of serum sodium and potassium levels in patients with senile cataract and age matched individuals without cataract. Indian J Ophthalmol. 2013;3:44-47. CrossRef PubMed
- 50. Rajakrishnan PDR. An analysis of the levels of serum sodium and potassium ions in senile cataract patients. Univ J Pre Para Clin Sci. 2016;2:1-6. Online Accessed July 2022.
- 51. Miglior S, Marighi PE, Musicco M, Balestreri C, Nicolosi A, Orzalesi N. Risk factors for cortical, nuclear, posterior subcapsular and mixed cataract: a case-control study. Ophthalmic Epidemiol. 1994;1(2):93-105. CrossRef PubMed
- 52. Donnelly CA, Seth J, Clayton RM, Phillips CI, Cuthbert J. Some plasma constituents correlate with human cataract location and nuclear colour. Ophthalmic Res. 1997;29(4):207-217. CrossRef PubMed
- 53. Duncan G, Bushell AR. Ion analyses of human cataractous lenses. Exp Eye Res. 1975;20(3):223-230. CrossRef PubMed
- 54. Chen CZ. [Analysis of 7 elements in the serum and lens of senile cataract patients]. Zhonghua Yan Ke Za Zhi. 1992;28(6):355-357. PubMed
- 55. Daba KT, Weldemichael DK, Mulugeta GA. Bilateral hypocalcemic cataract after total thyroidectomy in a young woman: case report. BMC Ophthalmol. 2019 21;19(1):233. CrossRef PubMed
- 56. Stolarz-Skrzypek K, Bednarski A, Czarnecka D, Kawecka-Jaszcz K, Staessen JA. Sodium and potassium and the pathogenesis of hypertension. Curr Hypertens Rep. 2013;15(2):122-130. CrossRef PubMed
- 57. Renzaho AMN, Burns C. Post-migration food habits of sub-Saharan African migrants in Victoria: a cross-sectional study. Nutr Diet. 2006;63(2):91-102. CrossRef
- 58. Elisaf M, Milionis H, Siamopoulos KC. Hypomagnesemic hypokalemia and hypocalcemia: clinical and laboratory characteristics. Miner Electrolyte Metab. 1997;23(2):105-112. PubMed
- 59. Abcar AC, Kujubu DA. Evaluation of hypertension with hypokalemia. Perm J. 2009;13(1):73-76. CrossRef PubMed